Changchun GeneScience Pharmaceutical Co., Ltd.
Changchun GeneScience Pharmaceutical Co., Ltd.
Explore linked clinical trials.50 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short Stature Children With Small for Gestational Age (SGA) | Small for Gestational Age | Not yet recruiting | Phase 3 | 2026-09-25 | NCT07841678 | |
| GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors. | Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated | Recruiting | Phase 1 | 2026-09-25 | NCT07407504 | |
| To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis. | Active Systemic Juvenile Idiopathic Arthritis | Recruiting | Not applicable | 2026-09-17 | NCT05925452 | |
| A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD) | Pediatric Growth Hormone Deficiency | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT07264595 | |
| A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion | Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, eye disorder, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Not yet recruiting | Phase 1 | 2026-09-14 | NCT07817615 | |
| Phase 1 Clinical Study of GenSci164 Injection | Healthy Adult Trial Participants | Not yet recruiting | Phase 1 | 2026-08-27 | NCT07790783 | |
| A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. | eye disorder, uveal disorder, uveitis | Recruiting | Phase 2 | 2026-07-24 | NCT07547995 | |
| Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, intestinal disorder, malabsorption syndrome, short bowel syndrome | Recruiting | Phase 4 | 2026-07-08 | NCT07691125 | |
| GenSci144 Tablets Phase I Clinical Trial | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuria | Recruiting | Phase 1 | 2026-07-06 | NCT07685210 | |
| A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV) | Bacterial Infections and Mycoses, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Urogenital Diseases, bacterial infectious disease, bacterial vaginosis, female reproductive system disorder, vaginal disorder, vaginitis | Not yet recruiting | Phase 1 | 2026-06-23 | NCT07663838 | |
| Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults | Healthy Adult Trial Participants | Not yet recruiting | Phase 1 | 2026-06-10 | NCT07638800 | |
| Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 2 | 2026-05-22 | NCT07423533 | |
| A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants | Absorption; Excretion; Healthy Postmenopausal Women; Metabolism | Active, not recruiting | Phase 1 | 2026-05-07 | NCT07537231 | |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants | Healthy Volunteers | Recruiting | Phase 1 | 2026-05-01 | NCT07476586 | |
| Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART) | Genital Diseases, Urogenital Diseases, infertility disorder | Not yet recruiting | Not stated | 2026-04-28 | NCT07553728 | |
| A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) | Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hypopituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder | Recruiting | Phase 1 | 2026-04-14 | NCT07016802 | |
| A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. | autoimmune disease, immune system disorder | Recruiting | Phase 1 | 2026-03-25 | NCT07366866 | |
| GS1-144 in Participants With Hepatic Impairment and Healthy Female | Hepatic Impairment and Healthy Female | Not yet recruiting | Phase 1 | 2026-03-24 | NCT07491289 | |
| A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults | Healthy Adults | Recruiting | Phase 1 | 2026-03-16 | NCT07473570 | |
| A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) | Idiopathic Short Stature | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT07450053 | |
| A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) | Pediatric Growth Hormone Deficiency | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT07450001 | |
| A Study of GensSci098 in Subjects With Graves' Disease | Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 1 | 2026-02-17 | NCT07286656 | |
| A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics | Short Stature Children Born Small for Gestational Age (SGA) | Recruiting | Phase 2 | 2026-02-17 | NCT07260500 | |
| A Study of GenSci098 in Subjects With Active Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 1 | 2026-02-11 | NCT06569758 | |
| Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma | Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Phase 3 | 2026-01-21 | NCT07356037 |